Search results
Egyptians Performed Brain Surgery 4,000 years ago: A Discovery Called a ‘Milestone in the History...
GoodNewsNetwork· 4 days agoAs with many things, a discovery from ancient Egypt has put a time stamp on the development of...
Trial of hormonal gel shows promise for male birth control
UPI· 5 hours agoA new hormonal gel could one day be a potential form of birth control for men, researchers reported...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 11 hours agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
...ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and...
The Grass Valley Union· 2 days ago...01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that results from the pivotal Phase 2 TRUST-I study...
Immunotherapy drug may keep colon cancer patients cancer-free after surgery
UPI· 7 hours agoDoctors in Britain say that an immunotherapy drug, given before surgery, can help many more colon...
Musk's Neuralink seeks to enroll three patients in brain implant study
KSL Salt Lake City· 7 days agoElon Musk's brain-chip startup, Neuralink, seeks to enroll three patients to evaluate its device in...
...Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1...
Morningstar· 3 days agoNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and ...
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following...
Digital Journal· 13 hours agoFahar Merchant, President and CEO...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
KOLR - KSFX Ozarks· 3 days agoEli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in patients with KRAS G12C-mutant advanced solid tumors ...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 4 days agoScientists have hailed the drug, called lorlatinib, for its “off the charts” results after a trial...